Patrizia Nanni

7PUBLICATIONS
11CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer cell biologyAutoimmunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 26, 2023
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy.

Francesca Ruzzi, Maria Sofia Semprini, Laura Scalambra

|Nov 14, 2021
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression.

Veronica Giusti, Francesca Ruzzi, Lorena Landuzzi

|Aug 07, 2021
HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy.

Carla De Giovanni, Lorena Landuzzi, Arianna Palladini

|Jan 20, 2021
IFN-γ and CD38 in Hyperprogressive Cancer Development.

Stefania Angelicola, Francesca Ruzzi, Lorena Landuzzi

|Apr 14, 2019
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R.

Carla De Giovanni, Lorena Landuzzi, Arianna Palladini

|Feb 09, 2019
Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis.

Carla De Giovanni, Patrizia Nanni, Lorena Landuzzi

Pageof 2